Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: A randomized, double blind, placebo-controlled trial

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 1, 2000, Pages 89-94

  Moghetti, Paolo ^a,c   Tosi, Flavia ^a   Tosti, Antonella ^b   Negri, Carlo ^a   Misciali, Cosimo ^b   Perrone, Fabrizia ^a   Caputo, Marco ^c   Muggeo, Michele ^a   Castello, Roberto ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c MAGGIORE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; FINASTERIDE; FLUTAMIDE; PLACEBO; SPIRONOLACTONE;

ADULT; ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HIRSUTISM; HUMAN; MICROSCOPY; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT OUTCOME;

ADULT; ALDOSTERONE ANTAGONISTS; ANDROGEN ANTAGONISTS; DOUBLE-BLIND METHOD; FEMALE; FINASTERIDE; FLUTAMIDE; HAIR; HIRSUTISM; HORMONES; HUMANS; POLYCYSTIC OVARY SYNDROME; SPIRONOLACTONE;

EID: 0034457586     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.1.89     Document Type: Article

References (42)

1. The treatment of women with hirsutism
2. Medical treatment of androgen-dependent hirsutism
3. Leuprolide and estrogen vs oral contraceptive pills for the treatment of hirsutism: A prospective randomized study
4. Hirsutism and the effectiveness of spironolactone in its management
5. Pharmacology and potential use of cyproterone acetate
6. Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues
7. Inhibition of rat testicular 17α-hydroxylase and 17,20-lyase activities by anti-androgens (flutamide, hydroxyflutamide, RU23908, cyproterone acetate) in vitro
8. Effects of flutamide and aminoglutethmide on plasma 5α-reduced steroid glucuronide concentrations in castrated patients with cancer of the prostate
9. Treatment of hirsutism with the pure antiandrogen flutamide
10. The impact of a pure anti-androgen (flutamide) on LH, FSH, androgens and clinical status in idiopathic hirsutism
11. Flutamide in the treatment of hirsutism: Long-term clinical effects, endocrine changes, and androgen receptor behavior
12. Fatal and nonfatal hepatotoxicity associated with flutamide
13. Genetic and pharmacological evidence for more than one human steroid 5α-reductase
14. Finasteride
15. Increased 5α reductase activity in idiopathic hirsutism
16. Clinical and hormonal effects of the 5α-reductase inhibitor finasteride in idiopathic hirsutism
17. A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women
18. Outcome of long-term treatment with the 5α-reductase inhibitor finasteride in idiopathic hirsutism: Clinical and hormonal effects during a 1-year course of therapy and 1-year follow-up
19. Gonadotropin-releasing hormone (GnRH) agonist and estrogen/progestin replacement for the treatment of hirsutism: Evaluating the results
20. How robust is the methodology for trials of therapy in hirsute women?
21. Clinical assessment of hair growth in women
22. Comparison of sequential cyproterone acetate/estrogen vs. spironolactone/oral contraceptive in the treatment of hirsutism
23. Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome
24. Hirsutism: Implications, etiology, and management
25. Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach
26. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion
27. Optical microscope system for standardized cell measurements and analyses
28. Comparison of flutamide and spironolactone in the treatment of hirsutism: A randomized controlled trial
29. Comparison of the efficacy of spironolactone vs. flutamide in the treatment of hirsutism
30. Comparison of oral contraceptive vs. cyproterone acetate-estrogen regimens in the treatment of hirsutism
31. Comparison of flutamide and cyproterone acetate in the treatment of hirsutism: A randomized controlled trial
32. Comparison of finasteride vs. spironolactone in the treatment of idiopathic hirsutism
33. Successful treatment of hirsutism in HAIR-AN syndrome using flutamide, spironolactone, and birth control therapy
34. Comparison of diane 35 and diane 35 plus spironolactone in the treatment of hirsutism
35. The clinical management of hirsutism
36. Treatment of hirsutism in women with flutamide
37. A comparison between two doses of flutamide (250 mg/d and 500 mg/d) in the treatment of hirsutism
38. The effect of finasteride, a 5α-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness
39. The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women
40. Hepatotoxicity complicating flutamide treatment of hirsutism
41. The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome
42. Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis